Local and Systemic Immunity against Respiratory Syncytial Virus Induced by a Novel Intranasal Vaccine. A Randomized, Double-Blind, Placebo-controlled Clinical Trial

Overview of attention for article published in American Journal of Respiratory & Critical Care Medicine, August 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

So far, Altmetric has seen 4 news stories from 2 outlets.

Patented technology applied in SynGEM, a needle-free nasal spray vaccine against respiratory syncytial virus * Re-Issuance of U.S…

An intranasal subunit vaccine (SynGEM) that introduces the respiratory syncytial virus (RSV), has demonstrated efficacy in…

SynGEM, an intranasal subunit vaccine that introduces the respiratory syncytial virus (RSV), has demonstrated efficacy in…

SynGEM a needle-free nasal spray vaccine against respiratory syncytial virus SynGEM shown to be safe and immunogenic in healthy…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity.